Lepu Biopharma Co., Ltd.
Clinical trials sponsored by Lepu Biopharma Co., Ltd., explained in plain language.
Biopharmaceutical company focused on innovative drugs for cardiovascular and metabolic diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New drug cocktail takes on advanced liver cancer
Disease control Recruiting nowThis early-phase trial tests a new drug called MRG006A, combined with immunotherapy and targeted therapy, in 160 people with advanced hepatocellular carcinoma (a type of liver cancer) that cannot be treated with surgery. The study aims to check safety, find the right dose, and se…
Phase: PHASE1, PHASE2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New drug cocktail aims to boost head and neck cancer surgery success
Disease control Recruiting nowThis phase II trial tests whether combining two drugs—pucotenlimab (an immunotherapy) and becotatug vedotin (a targeted chemotherapy)—given before and after surgery can improve outcomes for people with locally advanced head and neck cancer. About 80 participants will receive eith…
Phase: PHASE2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New virus therapy takes on tough bladder cancer
Disease control Recruiting nowThis phase 2 trial is testing a treatment called cretostimogene grenadenorepvec, a modified virus designed to infect and destroy cancer cells, in 16 people with high-risk bladder cancer that has not responded to standard BCG therapy. The study aims to see if the treatment can mak…
Phase: PHASE2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New cancer drug MRG006A enters human trials for advanced tumors
Disease control Recruiting nowThis study tests an experimental drug called MRG006A in 343 adults with advanced solid tumors that have spread or cannot be removed. The drug is given through a vein. The main goals are to find the safest dose and see if the drug can shrink tumors. The trial is currently recruiti…
Phase: PHASE1, PHASE2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC